Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus

Christopher Sjöwall; Ioannis Parodis

doi:10.3390/jcm11226869

Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus

J Clin Med. 2022 Nov 21;11(22):6869. doi: 10.3390/jcm11226869.

Authors

Christopher Sjöwall¹, Ioannis Parodis^{2

3}

Affiliations

¹ Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, SE-581 85 Linköping, Sweden.
² Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
³ Department of Rheumatology, Faculty of Medicine and Health, Örebro University, SE-701 82 Örebro, Sweden.

Abstract

The clinical presentation of systemic lupus erythematosus (SLE) is highly heterogeneous, ranging from mild disease limited to skin and joint involvement to life-threatening conditions with renal impairment, severe cytopenias, central nervous system disease, and thromboembolic events [...].

Publication types

Editorial

Grants and funding

This work was supported by grants from the Swedish Rheumatism Association (R-969696; R-939149), King Gustaf V’s 80-year Foundation (FAI-2020-0741; FAI-2020-0663), King Gustaf V and Queen Victoria’s Freemasons foundation (2021-22), Swedish Society of Medicine (SLS-974449), Nyckelfonden (OLL-974804); Professor Nanna Svartz Foundation (2020-00368), Ulla and Roland Gustafsson Foundation (2021-26), Region Stockholm (FoUI-955483), and Karolinska Institutet.